2017-2021 France Hospital Infectious Disease Market: Emerging Opportunities and Growth Strategies for Suppliers

February 2017 | 897 pages | ID: FEF33B73874EN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including:

• Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.
• Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories.
• Instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers by test.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.
• Business opportunities and strategic recommendations for suppliers.

Contains 897 pages and 77 tables

Contents

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major 1nfectious Disease Tests
  1. A1DS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  2. ADENO6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
    d. Adeno-Associated 5iruses(AA5)
  3. AEROMONAS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  4. ANTHRA10/BAC1LLUS ANTHRAC1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  5. ARBO6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  6. BABES1OS1S
    a. Background
  7. BAC1LLARY EP1THEL1O1D ANG1OMATOS1S (BEA) AND OTHER BARTONELLA (ROCHAL1MAEA)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  8. BLASTOCYST1S HOM1N1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  9. BRUCELLA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  10. CAMPYLOBACTER
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  11. CAND1DA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  12. CHAGAS D1SEASE
    a. Background
  13. CHANCRO1D
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  14. CHLAMYD1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  15. CLOSTR1D1UM D1FF1C1LE
    a. Background
    b. Diagnostic Tests
    c. Drugs and 5accines
  16. CORONA6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  17. CO10SACK1E6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  18. CREUTZFELDT-JAKOB’S D1SEASE
    a. Background
    b. Diagnostic Tests
    c. 5accines
  19. CRYPTOSPOR1D1UM PAR5UM
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  20. CYCLOSPORA CAYETANENS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  21. CYTOMEGALO6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  22. EBOLA 6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  23. E. COL1
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  24. ECHO6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  25. ENCEPHAL1T1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  26. ENTERO6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  27. EPSTE1N-BARR 6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  28. G1ARD1A LAMBL1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  29. GONORRHEA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  30. GRANULOMA 1NGU1NALE
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  31. HANTA6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  32. HEL1COBACTER PYLOR1
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  33. HEPAT1T1S
    a. Background
    b. Hepatitis A
    c. Hepatitis B
    d. Hepatitis C
    e. 5accines and Drugs
  34. HERPES S1MPLE10 6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  35. HUMAN HERPES 6RUS-6 (HH5-6)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  36. 1NFLUENZA 6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  37. LEG1ONELLA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  38. LYME D1SEASE
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  39. LYMPHOGRANULOMA 5ENEREUM (LG5)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  40. MALAR1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  41. MEASLES (RUBEOLA)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  42. MEN1NG1T1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  43. M1CROSPOR1D1UM
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  44. MONONUCLEOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  45. MUMPS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  46. MYCOPLASMA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  47. PAP1LLOMA6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  48. PAR5O6RUS B19
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  49. PNEUMON1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  50. POLYOMA6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  51. PSEUDOMONAS AERUG1NOSA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  52. RAB1ES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  53. RESP1RATORY SYNCYT1AL 6RUS (RS5)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  54. RH1NO6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  55. ROTA6RUS (REO6RUS)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  56. RUBELLA(MEASLES)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  57. SALMONELLOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  58. SEPT1CEM1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  59. SH1GELLOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  60. STAPHYLOCOCCUS AUREUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  61. STREPTOCOCC1
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  62. SYPH1L1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  63. TO10OPLASMOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  64. TR1CHOMONAS 5AG1NAL1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  65. TUBERCULOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  66. 6BR1O
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  67. WEST N1LE 6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  68. YERS1NA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
B. 1nstrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. MOLECULAR D1AGNOST1CS
  2. MONOCLONAL ANT1BOD1ES
  3. 1MMUNOASSAYS
  4. D1FFERENT1AL L1GHT SCATTER1NG
  5. 1NFORMAT1ON TECHNOLOGY
  6. ART1F1C1AL 1NTELL1GENCE
  7. L1POSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. D1AGNOST1C 1MAG1NG
  11. GEL M1CRODROPLETS
  12. OTHER
France A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. 1nstrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

L1ST OF TABLES

Major Companies Developing or Marketing A1DS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CM5 Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EB5 Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing 1nfluenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma 5irus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RS5 Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
France Summary Table All 1nfectious Diseases Test 5olume and Diagnostics Sales Forecast
France Hospital Laboratories Performing 1nfectious Disease Tests by Bed Size
France Hospital Laboratories 1nfectious Disease Test 5olume Forecast
France Hospital Laboratories 1nfectious Disease Diagnostics Market Forecast
France A1DS Testing Market Diagnostics Sales by Major Supplier
France Adenovirus Testing Market Diagnostics Sales by Major Supplier
France Campylobacter Testing Market Diagnostics Sales by Major Supplier
France Candida Testing Market Diagnostics Sales by Major Supplier
France Chlamydia Testing Market Diagnostics Sales by Major Supplier
France CM5 Testing Market Diagnostics Sales by Major Supplier
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Hepatitis Testing Market Diagnostics Sales by Major Supplier
France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
France Herpes Testing Market Diagnostics Sales by Major Supplier
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
France 1nfluenza Testing Market Diagnostics Sales by Major Supplier
France Meningitis Testing Market Diagnostics Sales by Major Supplier
France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
France Mumps Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France RS5 Testing Market Diagnostics Sales by Major Supplier
France Rotavirus Testing Market Diagnostics Sales by Major Supplier
France Rubella Testing Market Diagnostics Sales by Major Supplier
France Septicemia Testing Market Diagnostics Sales by Major Supplier
France Shigella Testing Market Diagnostics Sales by Major Supplier
France Streptococci Testing Market Diagnostics Sales by Major Supplier
France Syphilis Testing Market Diagnostics Sales by Major Supplier
France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
France Trichomonas Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier